Kymera Therapeutics, Inc. <KYMR.O>: Wells Fargo Raises Target Price to $151 From $116
KYMR•Related News
Dollar General Q2 Sales USD 11,290.38 Million Vs. IBES Estimate USD 11,197 Million
DG•
Choice Hotels International, Inc. <CHH.N>: Mizuho initiates coverage with neutral rating; target price $106
CHH•
Salesforce.com, Inc. <CRM.N>: Wells Fargo Raises Target Price to $230 From $205
CRM•
Fed's Warsh faces challenge whether inflation is a problem or not
SPY•
SmartStop Self Storage REIT Inc <SMA.N>: BMO cuts to market perform from outperform; raises target price to $38 from $36
SMA•